POTELIGEO conc perf 4 mg/ml flac
7680674440017
CH-67444
L01FX09
07.16.
Reimbursement limitations:
POTELIGEO.01
Poteligeo est remboursé en monothérapie systémique chez les patients adultes avec un diagnostic histologiquement confirmé …
1 / 3
google
Details
- Product number
- 6744401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- mogamulizumabum 20 mg, acidum citricum monohydricum, glycinum, polysorbatum 80, natrii hydroxidum q.s. ad pH, acidum hydrochloricum q.s. ad pH, aqua ad iniectabile ad solutionem pro 5 ml.
Articles (1)
Poteligeo 4 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1457.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2023
Authorization holder
Kyowa Kirin Sàrl
1201 Genève
Authorization information
- Swissmedic authorization number
- 67444
- Drug name
- Poteligeo, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FX09
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 01/09/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.
- Domain
- Human medicine
Packaging details
- Description (FR)
- POTELIGEO conc perf 4 mg/ml flac
- Description (DE)
- POTELIGEO Inf Konz 4 mg/ml Durchstf
- Market launch
- 01/09/2021
- Narcotic (BTM)
- No